Lv4
670 积分 2023-08-03 加入
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
5小时前
待确认
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials
5小时前
待确认
[Chinese expert consensus on the analytical validation of tumor comprehensive genomic profiling next generation sequencing testing (2024 edition)]
19天前
已完结
Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas
1个月前
已完结
[PIK3CA gene mutations in Chinese women with HR+/HER2- breast cancer]
1个月前
已完结
[Guidelines on clinical practice of molecular tests in non-small cell lung cancer in China (2024 version)]
2个月前
已完结
[The trend of accurate pathology diagnosis of breast cancer]
2个月前
已完结
Structural Variation Interpretation in the Genome Sequencing Era: Lessons from Cytogenetics
3个月前
已完结
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
4个月前
已完结
[Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)]
4个月前
已完结
皖公网安备34019202002308
